drugset / Trial / NCT00236847

A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

NCT00236847

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness and safety of topiramate as an add-on therapy in patients with uncontrolled partial onset seizures who are taking one or two standard antiepileptic drugs.

Timeline

Start
1989-12
Primary completion
Completion
1993-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 300 mg Oral

Indications